iReprogram Partners with University of Michigan on Multimillion-Dollar Initiative to Reprogram Cells for Diabetes
Backed by the Look to Michigan Strategic Initiative Fund, the collaboration aims to accelerate patient-derived cell therapies to pioneer comprehensive diabetes treatments. ANN ARBOR, Mich., Oct. 21, 2026 /PRNewswire/ -- iReprogram, spun out of the University of Michigan (U-M), was named...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.